Torsdag 24 April | 11:17:40 Europe / Stockholm
Svenska | English

Carnegie Access

Prenumeration

Ascelia Pharma: Interview – Q&A with Ascelia Pharma
2025-04-10 16:55:00

In a live interview, Magnus Corfitzen, CEO of Ascelia Pharma, answers questions regarding the current status of the company’s lead drug candidate, Orviglance, and its path toward potential market approval.

Find the interview on Carnegie Play: https://youtu.be/dkf3WyXIJuY
This is commissioned research from Carnegie Investment Bank. Read more here: https://www.carnegie.se/cr/

Information
This is a press release from Carnegie. For information about Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at cr@carnegie.se.

Contacts
Visiting address: Regeringsgatan 56, Stockholm
Site: http://www.carnegie.se
Telephone: +46 8-5886 88 00

About Us
Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. Carnegie operates in six countries and has more than 800 employees.

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden